| Kendra Ann Gottula, LPN | |
|
1829 Central Ave, Auburn, NE 68305-1713 | |
| (402) 274-4328 | |
| Not Available |
| Full Name | Kendra Ann Gottula |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1829 Central Ave, Auburn, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992314231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 20425 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kendra Ann Gottula, LPN 1829 Central Ave, Auburn, NE 68305-1713 Ph: (402) 274-4328 | Kendra Ann Gottula, LPN 1829 Central Ave, Auburn, NE 68305-1713 Ph: (402) 274-4328 |
News Archive
A wide income gap between the most affluent and the worst off in society is closely associated with higher death rates worldwide, especially for younger adults, finds a study published on bmj.com today as part of a global theme issue on poverty and human development.
Babies exposed to excess hormones in the womb are not only at increased risk of developing heart disease and diabetes in later life but can pass these risks to their children.
In a recent research letter published on the bioRxiv preprint server, scientists from Japan discovered that the mutation of spike glycoprotein in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) derived from farmed minks can also be found in the group of individuals with coronavirus disease (COVID-19) and subsequently evade detection by our immune system.
Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation, discovered that higher levels of these antibodies are linked to a lower heart attack risk.
In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trial - the first tests in adult volunteers - of its unique malaria vaccine candidate. Unlike other malaria vaccine candidates, Sanaria's approach deploys a weakened form of the whole malaria parasite harvested from irradiated mosquitoes instead of small portions of the parasite.
› Verified 5 days ago
Mrs. Mary Jo Huettner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 919 16th St, Auburn, NE 68305 Phone: 402-274-4354 Fax: 402-274-4356 | |
Ashley Genell Robertson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2103 O St, Auburn, NE 68305 Phone: 402-274-4129 | |
Ivon Jacqueline Johnson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 919 16th St, Auburn, NE 68305 Phone: 402-274-4354 |